Erythropoietin has an antiapoptotic effect after myocardial infarction and stimulates in vitro aortic ring sprouting

被引:5
作者
Broberg, Agneta Mansson [1 ]
Grinnemo, Karl-Henrik [2 ]
Genead, Rarni [1 ]
Danielsson, Christian [1 ]
Andersson, Agneta B. [1 ]
Wardell, Eva [1 ]
Sylven, Christer [1 ]
机构
[1] Karolinska Inst, Dept Cardiol, S-14186 Huddinge, Sweden
[2] Karolinska Univ Hosp, Dept Cardiothorac Surg, Stockholm, Sweden
关键词
erythropoietin; mouse; myocardial infarction; angiogenesis; apoptosis;
D O I
10.1016/j.bbrc.2008.04.025
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Aims were to explore if darbepoietin-alpha in mouse can induce angiogenesis and if moderate doses after myocardial infarction stimulates periinfarct capillary and arteriolar densities, cell proliferation, and apoptosis. Myocardial infarction was induced by ligation of LAD. Mouse aortic rings (0.8 mm) were cultured in matrigel and the angiogenic sprouting was studied after addition of darbepoietin-alpha with and without VEGF-165. After 12 days the hemoglobin concentration was 25% higher in the darbepoietin-alpha treated mice than in the control group. No difference in capillary densities in the periinfarct or noninfarcted areas was seen with darbepoietin-alpha. Cell proliferation was about 10 times higher in the periinfarct area than in the noninfarcted wall. Darbepoietin-alpha treatment led to a decrease of cell proliferation (BrdU, (p < 0.02)) and apoptosis (TUNEL, p < 0.005) with about 30% in the periinfarct area. Darbepoietin-alpha and VEGF-165 both independently induced sprouting from aortic rings. The results suggest that darbepoietin-alpha can induce angiogenesis but that moderate doses after myocardial infarction are not angiogenic but antiapoptotic. (c) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:75 / 78
页数:4
相关论文
共 12 条
[1]   Low-dose therapy with the long-acting erythropoietin analogue darbepoetin alpha persistently activates endothelial Akt and attenuates progressive organ failure [J].
Bahlmann, FH ;
Song, R ;
Boehm, SM ;
Mengel, M ;
von Wasielewski, R ;
Lindschau, C ;
Kirsch, T ;
de Groot, K ;
Laudeley, R ;
Niemczyk, E ;
Güler, F ;
Menne, J ;
Haller, H ;
Fliser, D .
CIRCULATION, 2004, 110 (08) :1006-1012
[2]   Erythropoietin enhances angiogenesis in an experimental cyclosporine A-induced nephrotoxicity model in the rat [J].
Efthimiadou, Anna ;
Pagonopoulou, Olga ;
Lambropoulou, Maria ;
Papadopoulos, Nikos ;
Nikolettos, Nikos K. .
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2007, 34 (09) :866-869
[3]   Angiogenic effects of dual gene transfer of bFGF and PDGF-BB after myocardial infarction [J].
Hao, X ;
Månsson-Broberg, A ;
Gustafsson, T ;
Grinnemo, KH ;
Blomberg, P ;
Siddiqui, AJ ;
Wärdell, E ;
Sylvén, C .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2004, 315 (04) :1058-1063
[4]   Recombinant epoetins do not stimulate tumor growth in erythropoietin receptor-positive breast carcinoma models [J].
LaMontagne, KR ;
Butler, J ;
Marshall, DJ ;
Tullai, J ;
Gechtman, Z ;
Hall, C ;
Meshaw, A ;
Farrell, FX .
MOLECULAR CANCER THERAPEUTICS, 2006, 5 (02) :347-355
[5]   Protective effects of erythropoietin in cardiac ischemia - From bench to bedside [J].
Lipsic, Erik ;
Schoemaker, Regien G. ;
van der Meer, Peter ;
Voors, Adriaan A. ;
van Veldhuisen, Dirk J. ;
van Gilst, Wiek H. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 48 (11) :2161-2167
[6]   Cardioprotection by recombinant human erythropoietin following acute experimental myocardial infarction: Dose response and therapeutic window [J].
Moon, C ;
Krawczyk, M ;
Paik, D ;
Lakatta, EG ;
Talan, MI .
CARDIOVASCULAR DRUGS AND THERAPY, 2005, 19 (04) :243-250
[7]   A novel protective effect of erythropoietin in the infarcted heart [J].
Parsa, CJ ;
Matsumoto, A ;
Kim, J ;
Riel, RU ;
Pascal, LS ;
Walton, GB ;
Thompson, RB ;
Petrofski, JA ;
Annex, BH ;
Stamler, JS ;
Koch, WJ .
JOURNAL OF CLINICAL INVESTIGATION, 2003, 112 (07) :999-1007
[8]   Combination of angiopoietin-1 and vascular endothelial growth factor gene therapy enhances arteriogenesis in the ischemic myocardium [J].
Siddiqui, AJ ;
Blomberg, P ;
Wärdell, E ;
Hellgren, I ;
Eskandarpour, M ;
Islam, KB ;
Sylvén, C .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2003, 310 (03) :1002-1009
[9]   Erythropoietin protects cardiac myocytes from hypoxia-induced apoptosis through an Akt-dependent pathway [J].
Tramontano, AF ;
Muniyappa, R ;
Black, AD ;
Blendea, MC ;
Cohen, I ;
Deng, LL ;
Sowers, JR ;
Cutaia, MV ;
El-Sherif, N .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2003, 308 (04) :990-994
[10]   Erythropoietin induces neovascularization and improves cardiac function in rats with heart failure after myocardial infarction [J].
van der Meer, P ;
Lipsic, E ;
Henning, RH ;
Boddeus, K ;
van der Velden, J ;
Voors, AA ;
van Veldhuisen, DJ ;
van Gilst, WH ;
Schoemaker, RG .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 46 (01) :125-133